Izafe Group

0.40 SEK

+17.21 %

Less than 1K followers

IZAFE B

First North Stockholm

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Dividend

Investor consensus

+17.21 %

-0.25 %

-11.04 %

-17.71 %

-41.91 %

+54.90 %

+36.21 %

-83.88 %

-88.62 %

iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions for home medication management. The company offers, among other things, a medication robot, SaaS solutions and a connected dosing bag. The products aim to reduce the risk of medication errors. Customers include individuals, pharmaceutical companies and public and private healthcare providers globally. iZafe Group is headquartered in Stockholm.

Market cap

170.08M SEK

Turnover

288.25K SEK

Revenue

5.99M

EBIT %

-280.14 %

P/E

-

Dividend yield-%

-

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

28.5

2026

General meeting '26

1.9

2026

Interim report Q2'26

3.11

2026

Interim report Q3'26

All

Press releases

ShowingAll content types

Press release5/8/2026, 11:30 AM

Monthly Letter April – Increased Activity and Growing Implementations

Regulatory press release4/28/2026, 6:30 AM

iZafe Group Q1 Interim Report, January-March 2026

Press release4/23/2026, 6:30 AM

Dosell awarded contract with Västervik Municipality regarding medication dispensing devices

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release4/13/2026, 9:00 AM

iZafe Group Achieves ISO/IEC 27001 Certification and Strengthens Its Position for International Expansion

Press release4/10/2026, 6:30 AM

Monthly Update March – ADDA in effect and preparations for the next growth phase

Press release4/7/2026, 6:30 AM

Dosell AB awarded contract with Region Jönköping County and its municipalities

Press release4/1/2026, 7:00 AM

Dosell AB Granted European Patent in Data-Driven Medication Management

Press release3/12/2026, 3:00 PM

Dosell AB signs framework agreement with Adda following the end of the appeal period

Regulatory press release3/12/2026, 2:00 PM

Communiqué from the Extraordinary General Meeting of iZafe Group AB

Press release3/9/2026, 8:00 AM

Monthly Letter February – ADDA, Growth Capital and Preparations for Scaling

Press release2/26/2026, 3:10 PM

Dosell Awarded Framework Agreement in Sweden’s First National Procurement of Medication Dispensing Systems

Regulatory press release2/19/2026, 7:40 AM

iZafe Group AB has resolved on a directed share issue of class B shares of approximately SEK 19.8 million in order to accelerate the pace of sales and installations.

Regulatory press release2/16/2026, 7:30 AM

iZafe Group’s Quarterly Report Q4, October–December 2025

Press release2/10/2026, 8:00 AM

Monthly Update January – Broad Momentum and the Launch of a New Platform

Press release1/21/2026, 8:00 AM

iZafe Group launches modular Display and remote care system – one Dosell for all users

Press release1/12/2026, 10:00 AM

Monthly Update December – A Year of Breakthroughs, Expansion and International Consolidation

Regulatory press release12/16/2025, 4:00 PM

iZafe Group AB (publ.) – Exercise of Warrants under LTIP 2023

Press release12/8/2025, 9:00 AM

Monthly Newsletter – November: Momentum, Deliveries, and Continued Expansion

Press release11/28/2025, 8:15 AM

Board Member Increases Shareholding in iZafe Group

Press release11/21/2025, 7:30 AM

iZafe Group strengthens its Nordic expansion through strategic partnership and first major deal in Norway

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.